Macas, Leonora S.
HRN: 18-85-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2023
CO-AMOXICLAV 625MG (TAB)
04/14/2023
04/21/2023
PO
625mg
BiD
S/P Excision Of Mass
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes